Factors such as the increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market.
What the Market Looks Like?
Predicted to grow at a CAGR of 10.10% during the forecast period, the global Cellular Health Testing marketis estimated to reach USD 3.42 billion by the end of 2022.
“Single test panels to dominate the market in 2017”
Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. In 2017, the single test panels segment is expected to account for the largest share of the global cellular health screening market.
“Based on sample collection site, the at-home segment is projected to grow at the highest CAGR”
By sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. The at-home segment is expected to register the highest CAGR during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930
Geographical growth scenario of Cellular Health Testing Market
In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region. In 2017, Europe is expected to hold the second largest share of this market.
Leading market players
The prominent players in the Cellular Health Testing market include Genova Diagnostics (U.S.), Telomere Diagnostics (U.S.), Life Length (Spain), Quest Diagnostics (U.S.), Repeat Diagnostics (Canada), SpectraCell Laboratories (U.S.), Zimetry LLC (U.S.), Cell Science Systems (U.S.), Titanovo, Inc. (U.S.), Segterra, Inc. (U.S.), LabCorp Holdings (U.S.), BioReference Laboratories (U.S.), Immundiagnostik AG (Germany), DNA Labs (India), and Cleveland HeartLab, Inc. (U.S.).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=227041930